A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/1999
10/20/1999	EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999	EP0740655B1 Metalloproteinase inhibitors
10/20/1999	CN1232501A Modified TIE-2 -receptor ligands
10/20/1999	CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999	CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999	CN1232448A Vitamin D analogues
10/20/1999	CN1232398A IL-8 receptor antagonists
10/20/1999	CN1232395A Pharmaceutical compound comprising polyamines substd. with electron-affinic groups
10/20/1999	CN1231923A Psoriasis wine and its producing process
10/20/1999	CN1231903A Medicine capable of regenerating muscle around exposed bone, and its preparing method
10/20/1999	CN1231897A Liquid medicine for treatment of bromidrosis, and its preparing method
10/19/1999	US5969190 Cyclohexanediol derivatives
10/19/1999	US5969184 Amide compounds
10/19/1999	US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents
10/19/1999	US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999	US5968809 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/19/1999	US5968532 Substance p antagonists
10/19/1999	US5968524 Methods and compounds for the treatment of immunologically-mediated psoriasis
10/19/1999	US5968487 Derivative of kojic acid and its use as a depigmenting agent
10/19/1999	US5968485 UV protection compositions
10/19/1999	US5968482 Radiation resistant filters for light protection of cosmetics and drugs
10/14/1999	WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999	WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999	WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999	WO1999051580A1 Pyrazole inhibitors of cytokine production
10/14/1999	WO1999051220A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin
10/14/1999	WO1999051213A2 The use of polyamines in the treatment of dermatological symptoms
10/14/1999	WO1999051200A1 Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids
10/14/1999	WO1999043809A3 Protease-activated receptor 4 and uses thereof
10/14/1999	DE19815090A1 Kosmetische Mittel Cosmetic Products
10/14/1999	CA2327185A1 Pyrazole inhibitors of cytokine production
10/14/1999	CA2326522A1 Pyrrolo¬1,2-a\|pyrazine spla2 inhibitor
10/14/1999	CA2326507A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin
10/14/1999	CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999	CA2324984A1 Secreted proteins and polynucleotides encoding them
10/13/1999	EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999	EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999	EP0948544A1 Monovalent antibody fragments
10/13/1999	EP0948538A1 Analysis and separation of platelet-derived growth factor proteins
10/13/1999	EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999	EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999	EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999	EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999	EP0948489A1 Piperazine compounds as inhibitors of mmp or tnf
10/13/1999	EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999	EP0948313A2 Use of an extract of gaboon resin in cosmetics and pharmaceutics, in particular for dermatological purposes
10/13/1999	EP0948308A1 Methods for treating skin pigmentation
10/13/1999	EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999	CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999	CN1231610A Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
10/13/1999	CN1231606A Composition comprising mupirocin and chlorhexidine
10/13/1999	CN1231203A Ointment for rheumatic spur
10/13/1999	CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/12/1999	US5965725 Polypeptides, and preparation and DNA encoding thereof
10/12/1999	US5965618 Treatment of scar tissue using lipoic acid
10/12/1999	US5965615 Hydroxyl radical scavenger
10/12/1999	US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999	US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999	US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999	US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999	US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999	US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999	US5965551 Method of treating alopecia
10/12/1999	US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999	US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999	US5965125 Hybrid matrix implants and explants
10/12/1999	CA2012219C D-desosamine retinoic esthers, process for their preparation and use in human or veterinary and in cosmetology
10/07/1999	WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999	WO1999050262A1 Pde iv inhibiting pyridine derivatives
10/07/1999	WO1999050239A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
10/07/1999	WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999	WO1999049887A1 Use of protease inhibitors for treating skin wounds
10/07/1999	WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999	WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999	WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999	WO1999049841A1 Skin care compositions
10/07/1999	WO1999049839A1 Topical liquid composition for promoting hair growth and process of manufacturing thereof
10/07/1999	WO1999049838A1 Use of retinoic acid activity inhibitors to slow down hair loss
10/07/1999	WO1999040220A3 Method of screening therapeutic agents
10/07/1999	DE19910856A1 Strukturiertes Wasser für eine verbesserte Anfeuchtung Structured water for improved wetting
10/07/1999	DE19901270A1 Production of beta-1,6-branched beta-1,3-glucan useful as skin anti-aging, depigmenting and healing agent
10/07/1999	DE19814358A1 Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn Use of alkyl hydrogen for the treatment of psoriasis, psoriatic arthritis, atopic dermatitis, and Crohn's disease
10/07/1999	CA2326438A1 Use of protease inhibitors for treating skin wounds
10/07/1999	CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999	CA2324899A1 Use of retinoic acid activity inhibitors to slow down hair loss
10/07/1999	CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999	CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/06/1999	EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999	EP0947192A1 Transparent antidandruff shampoos
10/06/1999	EP0946736A1 Method for expression of heterologous proteins in yeast
10/06/1999	EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999	EP0946587A2 New amide compounds
10/06/1999	EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999	EP0946554A1 Fused bicyclic pyrimidine derivatives
10/06/1999	EP0946541A1 Quinolines and their therapeutic use
10/06/1999	EP0946485A2 Method for treatment of dermatological disorders
10/06/1999	EP0946196A1 Method for treating symptoms of diabetes
10/06/1999	EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999	EP0946155A1 Pharmaceutical composition for treating fecal incontinence and anal itch
10/06/1999	EP0946140A1 Use of an extract of cordia dichotoma

1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 1065